Locust Walk is a global investment bank that integrates the best of strategy consulting with strategic transactions and capital raising for innovative life science companies.  We support management and board members through all aspects of a deal – from clearly defining and assessing all options to developing company positioning and navigating through the full deal cycle from outreach to term sheet structuring to negotiating to close. Our suite of capabilities and data driven approach provides our clients with greater confidence on decision making, faster execution, and less friction working with a single team throughout the process.

 

Walk with us. Together, we’ll build lasting value.

Thought Leadership

Latest Transactions

Garuda Therapeutics

Garuda Therapeutics Launches with $72 Million Series A Financing

LWAC and eFFECTOR Therapeutics 

LWAC’s Stockholders Approve Business Combination with eFFector Therapeutics to Create Next-Generation Oncology Company Developing New Class of Cancer Therapies

Locust Walk Acquisition Corp.

Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option

arrows-right-blueCapabilities

Corporate, R&D, BD, and financing strategy and commercial analytics with strategic transactions and capital markets execution

arrows-right-orangeEngaging with us

Global reach with on-the-ground local presence and company and investor relationships in all major life science markets

arrows-right-tealIndustry Segments

Comprehensive coverage across biopharma segments

Each quarter we compile key statistics and trends on strategic transactions and financings.

You can download your report here.

Each quarter we compile key statistics and trends on strategic transactions and financings.

You can download your report here.

Each quarter we compile key statistics and trends on strategic transactions and financings.

You can download your report here.

A Track Record of Success

Locust Walk has supported our clients through more than 400 projects generating nearly $1B of deal value spanning buy-side/sell-side transactions, capital raises, and commercialization strategies at the company, portfolio, and asset level. Examples of recent client engagements click the link below. We would encourage you to click on each case study and/or press release to learn about each assignment in greater detail. 

VIEW OUR CASE STUDIES »

Securities offered through Locust Walk Securities, LLC, member FINRA/SIPC.